Acurx Pharmaceuticals Inc.

ACXP | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.33

-$0.06 (-4.32%)

At close: Sep 21, 2026, 4:00 PM ET

$1.35

+$0.02 (+1.50%)

Pre-market: Sep 22, 2026, 8:10 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Quarter Period Ending	Q2 2026 Jun 29, 2026	Q1 2026 Mar 30, 2026	Q4 2025 Dec 30, 2025	Q3 2025 Sep 29, 2025	Q2 2025 Jun 29, 2025	Q1 2025 Mar 30, 2025	Q4 2024 Dec 30, 2024	Q3 2024 Sep 29, 2024	Q2 2024 Jun 29, 2024	Q1 2024 Mar 30, 2024	Q4 2023 Dec 30, 2023	Q3 2023 Sep 29, 2023	Q2 2023 Jun 29, 2023	Q1 2023 Mar 30, 2023	Q4 2022 Dec 30, 2022	Q3 2022 Sep 29, 2022	Q2 2022 Jun 29, 2022	Q1 2022 Mar 30, 2022	Q4 2021 Dec 30, 2021	Q3 2021 Sep 29, 2021	Q2 2021 Jun 29, 2021	Q1 2021 Mar 30, 2021
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	-2.31M	-1.72M	-1.62M	-2.03M	-2.27M	-2.15M	-2.78M	-2.82M	-4.12M	-4.38M	-5.11M	-3.11M	-3.45M	-2.9M	-3.26M	-3.54M	-2.62M	-2.67M	-2.63M	-4.64M	-4.07M	-1.47M
Interest Income	53.06K	35.01K	38.84K	35.91K	23.4K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	-2.25M	-1.68M	-1.58M	-1.99M	-2.25M	-2.15M	-2.78M	-2.82M	-4.12M	-4.38M	-5.11M	-3.11M	-3.45M	-2.9M	-3.26M	-3.54M	-2.62M	-2.67M	-2.63M	-4.64M	-4M	-1.47M
Net Income	-2.25M	-1.68M	-1.58M	-1.99M	-2.25M	-2.15M	-2.78M	-2.82M	-4.12M	-4.38M	-5.11M	-3.11M	-3.45M	-2.9M	-3.26M	-3.54M	-2.62M	-2.67M	-2.63M	-4.64M	-4M	-1.47M
Selling & General & Admin	1.24M	1.37B	6.25B	1.6M	1.75M	1.55M	1.96M	1.62M	2.3M	2.82M	3.17M	1.77M	1.71M	1.89M	1.83M	1.95M	1.71M	1.85M	1.91M	3.52M	3.98M	1.38M
Research & Development	1.07M	341.47K	1.83B	429.69K	524.21K	598.8K	825.06K	1.2M	1.83M	1.56M	1.94M	1.35M	1.74M	1.02M	1.43M	1.59M	911.69K	818.89K	716.22K	1.13M	95.07K	91.91K
Other Expenses	n/a	-1.37B	-8.08B	n/a	n/a	0	0	0	n/a	n/a	0	0	0	n/a	n/a	0	0	n/a	0	n/a	n/a	n/a
Operating Expenses	2.31M	1.72M	1.62M	2.03M	2.27M	2.15M	2.78M	2.82M	4.12M	4.38M	5.11M	3.11M	3.45M	2.9M	3.26M	3.54M	2.62M	2.67M	2.63M	4.64M	4.07M	1.47M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	-1.6M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	716.68K	n/a	n/a	n/a	3.35M	n/a
Cost & Expenses	2.31M	1.72M	1.62M	2.03M	2.27M	2.15M	2.78M	2.82M	4.12M	4.38M	5.11M	3.11M	3.45M	2.9M	3.26M	3.54M	2.62M	2.67M	2.63M	4.64M	4.07M	1.47M
Income Tax Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Shares Outstanding (Basic)	4.26M	1.5M	1.5M	1.63M	1.19M	1M	851.55K	818.15K	791.25K	773.65K	673.1K	650.25K	609.3K	581.95K	580.3K	557.4K	513.15K	511.65K	511.23K	505.8K	348.4K	477.05K
Shares Outstanding (Diluted)	4.26M	1.5M	1.5M	1.63M	1.19M	1M	851.55K	818.15K	791.25K	773.65K	673.1K	650.25K	609.3K	581.95K	580.3K	557.4K	513.15K	511.65K	511.23K	505.8K	348.4K	477.05K
EPS (Basic)	-0.53	-1.12	-0.67	-1.23	-1.89	-2.14	-3.27	-3.45	-5.21	-5.66	-7.60	-4.79	-5.60	-5	-5.62	-6.40	-5.20	-5.20	-5.20	-9.20	-11.40	-3
EPS (Diluted)	-0.53	-1.12	-0.67	-1.23	-1.89	-2.14	-3.27	-3.45	-5.21	-5.66	-7.60	-4.79	-5.60	-5	-5.62	-6.40	-5.20	-5.20	-7.60	-9.20	-11.40	-3
EBITDA	-2.31M	-1.68M	-1.58M	-1.99M	-2.25M	n/a	n/a	n/a	-4.12M	-4.38M	n/a	n/a	n/a	-2.9M	n/a	n/a	n/a	-2.67M	n/a	n/a	66.5K	n/a
EBIT	-2.31M	-1.68M	-1.58M	-1.99M	-2.25M	-2.15M	-2.78M	-2.82M	-4.12M	-4.38M	-5.11M	-3.11M	-3.45M	-2.9M	-3.26M	-3.54M	-2.62M	-2.67M	-2.63M	-4.64M	-4M	-1.47M
Depreciation & Amortization	n/a	n/a	n/a	n/a	n/a	2.15M	2.78M	2.82M	n/a	n/a	5.11M	3.11M	3.45M	n/a	3.26M	3.54M	2.62M	n/a	2.63M	4.64M	4.07M	1.47M